Atherosclerosis ranks first among cardiovascular system diseases. It is the “disease of the
century”, and more than 50% of people with circulatory pathology die of it. The clinical …

Dyslipidemias or dyslipoproteinemias are quantitative changes in total cholesterol
concentration, respective fractions, or triglycerides in the plasma. Evidence supported that …

The atherosclerotic process starts in childhood and studies show its development in fetuses.
Clinical manifestation often occurs only in the sixth decade of life. Adolescence is a critical …

There is an increasing interest in dyslipidemia in adult patients since it is known to contribute
to early cardiovascular disease. Often, dyslipidemia starts in childhood, and it is associated …

Dyslipidemia is an important etiologic factor in the development of cardiovascular disease
(CVD), which is a leading cause of death worldwide As CVD begins in childhood, and as …

In infancy, atherosclerosis is a preclinical disorder in which dyslipidemia plays a crucial role.
Due to its impact on cardiovascular structures, potentially reversible during childhood …

In adults, dyslipidemia is an established risk factor for atherosclerotic cardiovascular disease
(ASCVD), and correcting dyslipidemia reduces the risk of ASCVD. Dyslipidemia often begins …

Atherosclerosis begins in youth and is directly linked with the presence and severity of
cardiovascular risk factors, including dyslipidemia. Thus, the timely identification and …

Background/Aims: Cardiovascular disease is the most prominent cause of mortality
worldwide. A key risk factor for atherosclerotic cardiovascular disease is the presence of …

Background: Dyslipidemia is considered as an important modifiable risk factor for
cardiovascular disease (CVD). The link between childhood dyslipidemia and occurrence of …